Through spatial transcriptomic analysis of HCC patients [43], we observe high expression levels of METTL16, an enzyme responsible for RNA m6A modification, within HCC tumor regions compared to adjacent normal tissue or non-tumor regions (Fig. 1A). Here, METTL16 is linked to neoplasm.